Related references
Note: Only part of the references are listed.Differential Regulation of Indoleamine-2,3-Dioxygenase (IDO) by HIV Type 1 Clade B and C Tat Protein
Thangavel Samikkannu et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease
Antonio Macchiarulo et al.
AMINO ACIDS (2009)
The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease
Krystyna Pawlak et al.
ATHEROSCLEROSIS (2009)
The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology
Antonio Curti et al.
BLOOD (2009)
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes
Madhav D. Sharma et al.
BLOOD (2009)
IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism
Stefan Loeb et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase-Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer
Feng Qian et al.
CANCER RESEARCH (2009)
IDO recruits Tregs in melanoma
George C. Prendergast et al.
CELL CYCLE (2009)
Elevated Expression of Indoleamine 2,3-Dioxygenase (IDO) and Accumulation of Kynurenic Acid in the Pathogenesis of STZ-Induced Diabetic Cataract in Wistar Rats
Vangipurapu Rajani Kanth et al.
CURRENT EYE RESEARCH (2009)
Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases
P. H. Tan et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Immunomodulatory effects of Turkish propolis: Changes in neopterin release and tryptophan degradation
Gozde Girgin et al.
IMMUNOBIOLOGY (2009)
Indoleamine 2,3-Dioxygenase in Intestinal Immunity and Inflammation
Bobby J. Cherayil
INFLAMMATORY BOWEL DISEASES (2009)
Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway
Helen J. Ball et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Parameters of Soluble Immune Activation In Vivo Correlate Negatively With the Proliferative Capacity of Peripheral Blood Mononuclear Cells In Vitro in HIV-Infected Patients
Katharina Schroecksnadel et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Curcumin Suppresses the Induction of Indoleamine 2,3-Dioxygenase by Blocking the Janus-activated Kinase-Protein Kinase Cδ-STAT1 Signaling Pathway in Interferon-γ-stimulated Murine Dendritic Cells
Young-Il Jeong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow Conditions
Marita C. Barth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cacao extracts suppress tryptophan degradation of mitogen-stimulated peripheral blood mononuclear cells
M. Jenny et al.
JOURNAL OF ETHNOPHARMACOLOGY (2009)
Progression of Pancreatic Adenocarcinoma Is Significantly Impeded with a Combination of Vaccine and COX-2 Inhibition
Pinku Mukherjee et al.
JOURNAL OF IMMUNOLOGY (2009)
The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity
Grant N. Scott et al.
JOURNAL OF IMMUNOLOGY (2009)
Combined Effect of Antiretroviral Therapy and Blockade of IDO in SIV-Infected Rhesus Macaques
Adriano Boasso et al.
JOURNAL OF IMMUNOLOGY (2009)
Blockade of Indoleamine 2,3-Dioxygenase Protects Mice against Lipopolysaccharide-Induced Endotoxin Shock
In Duk Jung et al.
JOURNAL OF IMMUNOLOGY (2009)
Indoleamine 2,3-dioxygenase overexpression causes kynurenine-modification of proteins, fiber cell apoptosis and cataract formation in the mouse lens
Maneesh Mailankot et al.
LABORATORY INVESTIGATION (2009)
Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host
Teresa Zelante et al.
MICROBES AND INFECTION (2009)
The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons
Abdur Rahman et al.
PLOS ONE (2009)
Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease
Krystyna Pawlak et al.
THROMBOSIS RESEARCH (2009)
TGF-β and kynurenines as the key to infectious tolerance
Maria L. Belladonna et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
S. Rutella et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2009)
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Stefan Loeb et al.
NATURE REVIEWS CANCER (2009)
Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality
Lisa K. Jasperson et al.
BLOOD (2008)
Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: Its association with disease progression and survival
Kazuhiko Ino et al.
CLINICAL CANCER RESEARCH (2008)
Emerging concepts in CD8+ T regulatory cells
Jerry Y. Niederkorn
CURRENT OPINION IN IMMUNOLOGY (2008)
T cells, B cells, and polarized pathogenesis of fibrosis and immune response in the systemic sclerosis
Carlo Chizzolini
CURRENT OPINION IN RHEUMATOLOGY (2008)
The concentration of kynurenine in rat model of asthma
Iwona Kucharewicz et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2008)
Toxicology and pharmacokinetics of 1-methyl-D-tryptophan: Absence of toxicity due to saturating absorption
Lee Jia et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Twelve immunotherapy drugs that could cure cancers
Martin A. ‘Mac’ Cheever
IMMUNOLOGICAL REVIEWS (2008)
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells
Ilaria Marigo et al.
IMMUNOLOGICAL REVIEWS (2008)
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape
Jessica B. Katz et al.
IMMUNOLOGICAL REVIEWS (2008)
Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase
Alberto Molano et al.
IMMUNOLOGY LETTERS (2008)
IDO: A double-edged sword for TH1/TH2 regulation
Hui Xu et al.
IMMUNOLOGY LETTERS (2008)
Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitis
Lynne Harrington et al.
INFECTION AND IMMUNITY (2008)
Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model
Yousef A. Taher et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism
Olivier Manches et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Cutting edge:: Autocrine TGF-β sustains default tolerogenesis by IDO-competent dendritic cells
Maria L. Belladonna et al.
JOURNAL OF IMMUNOLOGY (2008)
The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation
Wei Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors
Sanjeev Kumar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A
Gavin Carr et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase
Sanjeev Kumar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection
Agnes Witkiewicz et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease
Luigina Romani et al.
NATURE (2008)
Biomimetic synthesis of the IDO inhibitors exiguamine A and B
Matthew Volgraf et al.
NATURE CHEMICAL BIOLOGY (2008)
Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I
Tiziana Di Pucchio et al.
NATURE IMMUNOLOGY (2008)
Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder
Christine L. Miller et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
Immune escape as a fundamental trait of cancer: focus on IDO
G. C. Prendergast
ONCOGENE (2008)
Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation
Hui Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis
Ciriana Orabona et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase
Alexander J. Muller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: The Health 2000 study
P. Niinisalo et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2008)
Nonimmune cells in inflammatory bowel disease: from victim to villain
Silvio Danese
TRENDS IN IMMUNOLOGY (2008)
A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase
T. Banerjee et al.
ONCOGENE (2008)
Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells
Stefan Lob et al.
BLOOD (2008)
Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury
Kanishka Mohib et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma
Rainer Riesenberg et al.
CLINICAL CANCER RESEARCH (2007)
Regulatory T-Cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection
Adriano Boasso et al.
JOURNAL OF VIROLOGY (2007)
NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis
Masaki Terabe et al.
TRENDS IN IMMUNOLOGY (2007)
Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season
M. Pertovaara et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Severe tryptophan starvation blocks onset of conventional persistence and reduces reactivation of Chlamydia trachomatis
Ralf M. Leonhardt et al.
INFECTION AND IMMUNITY (2007)
Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice
Katsuhide Okunishi et al.
JOURNAL OF IMMUNOLOGY (2007)
IDO and regulatory T cells:: a role for reverse signalling and non-canonical NF-κB activation
Paolo Puccetti et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle
Thijs Kaper et al.
PLOS BIOLOGY (2007)
Noncanonical NF-κB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation
Sander W. Tas et al.
BLOOD (2007)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Helen J. Ball et al.
GENE (2007)
Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer
Takafumi Nakamura et al.
CANCER SCIENCE (2007)
Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy
Ursula Grohmann et al.
NATURE MEDICINE (2007)
HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells
Adriano Boasso et al.
BLOOD (2007)
Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study
M. Pertovaara et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
(-)-Epigallocatechin gallate suppresses indoleamine 2,3-dioxygenase expression in murine dendritic cells: Evidences for the COX-2 and STAT1 as potential targets
Young-Il Jeong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase
A. Curti et al.
LEUKEMIA (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19(+) dendritic cells
Anna K. Manlapat et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
The terminology issue for myeloid-derived suppressor cells
Dmitry I. Gabrilovich et al.
CANCER RESEARCH (2007)
Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice
Sandor Szanto et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Exiguamine A, an indoleamine-2,3-dioxygenase (IDO) inhibitor isolated from the marine sponge Neopetrosia exigua
Harry C. Brastianos et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition
Lingqiao Zhu et al.
JOURNAL OF IMMUNOLOGY (2006)
A high-affinity, tryptophan-selective amino acid transport system in human macrophages
Robert L. Seymour et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific marine hydroid Garveia annulata
Alban Pereira et al.
JOURNAL OF NATURAL PRODUCTS (2006)
Tolerogenic dendritic cells: cytokine modulation comes of age
Sergio Rutella et al.
BLOOD (2006)
Mast cells are essential intermediaries in regulatory T-cell tolerance
Li-Fan Lu et al.
NATURE (2006)
1-methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity
Sophie Agaugue et al.
JOURNAL OF IMMUNOLOGY (2006)
Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: Role of IDO
Gargi D Basu et al.
JOURNAL OF IMMUNOLOGY (2006)
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
Alexander J. Muller et al.
NATURE REVIEWS CANCER (2006)
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition
Michael S. von Bergwelt-Baildon et al.
BLOOD (2006)
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features
Sergio Rutella et al.
BLOOD (2006)
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO
Maria L. Belladonna et al.
JOURNAL OF IMMUNOLOGY (2006)
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells
Francesca Fallarino et al.
JOURNAL OF IMMUNOLOGY (2006)
Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation
DH Munn
CURRENT OPINION IN IMMUNOLOGY (2006)
Crystal structure of human indoleamine 2,3-dioxygenase:: Catalytic mechanism of O2 incorporation by a heme-containing dioxygenase
H Sugimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer:: Effect on tumor-infiltrating T cells
G Brandacher et al.
CLINICAL CANCER RESEARCH (2006)
The immunoregulatory role of IDO-producing human dendritic cells revisited
P Terness et al.
TRENDS IN IMMUNOLOGY (2006)
Structure-activity study of Brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors
P Gaspari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Th17: An effector CD4 T cell lineage with regulatory T cell ties
Casey T. Weaver et al.
IMMUNITY (2006)
Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite
M Platten et al.
SCIENCE (2005)
Regulatory T cells for immunotherapy of autoimmune diseases: from the bench to the bedside
S Rutella et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2005)
Cutting edge:: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN type 1 signaling
AL Mellor et al.
JOURNAL OF IMMUNOLOGY (2005)
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
D Braun et al.
BLOOD (2005)
Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis
R Potula et al.
BLOOD (2005)
A novel role of hepatocyte growth regulator through suppressing factor as an immune dendritic cell function
K Okunishi et al.
JOURNAL OF IMMUNOLOGY (2005)
Marrying immunotherapy with chemotherapy: why say IDO?
AJ Muller et al.
CANCER RESEARCH (2005)
Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells
A Okamoto et al.
CLINICAL CANCER RESEARCH (2005)
Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors
AJ Muller et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime?
BC Fuchs et al.
SEMINARS IN CANCER BIOLOGY (2005)
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
DH Munn et al.
IMMUNITY (2005)
Opinion - Immunotherapy and chemotherapy - a practical partnership
RA Lake et al.
NATURE REVIEWS CANCER (2005)
IRF-7 is the master regulator of type-I interferon-dependent immune responses
K Honda et al.
NATURE (2005)
Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro
K Schroecksnadel et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
AJ Muller et al.
NATURE MEDICINE (2005)
Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells
DH Munn et al.
JOURNAL OF IMMUNOLOGY (2004)
Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific
B Baban et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2004)
In vitro effects of two extracts and two pure alkaloid preparations of Uncaria tomentosa on peripheral blood mononuclear cells
C Winkler et al.
PLANTA MEDICA (2004)
Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells
MT Travers et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)
Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma
Y Akasaki et al.
JOURNAL OF IMMUNOLOGY (2004)
St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro
C Winkler et al.
BIOLOGICAL CHEMISTRY (2004)
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
DH Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Cutting edge: Human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase
SO Odemuyiwa et al.
JOURNAL OF IMMUNOLOGY (2004)
Interferon-γ-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis
SB Adikari et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
IDO and tolerance to tumors
DH Munn et al.
TRENDS IN MOLECULAR MEDICINE (2004)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Modulation of tryptophan catabolism by regulatory T cells
F Fallarino et al.
NATURE IMMUNOLOGY (2003)
Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise
AJ Dannenberg et al.
CANCER CELL (2003)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma
JR Lee et al.
LABORATORY INVESTIGATION (2003)
Reconstructing eukaryotic NAD metabolism
A Rongvaux et al.
BIOESSAYS (2003)
T cell apoptosis by tryptophan catabolism
I Fallarino et al.
CELL DEATH AND DIFFERENTIATION (2002)
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase
DH Munn et al.
SCIENCE (2002)
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
G Frumento et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells:: Mediation of suppression by tryptophan metabolites
P Terness et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-associated cells:: Implications for persistent Chlamydophila pneumoniae infection
JB Sakash et al.
INFECTION AND IMMUNITY (2002)
Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer
A Huang et al.
BRITISH JOURNAL OF CANCER (2002)
The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants
Y Kudo et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Hepatocyte growth factor is a regulator of monocyte-macrophage function
F Galimi et al.
JOURNAL OF IMMUNOLOGY (2001)
Analysis of transcription factors regulating induction of indoleamine 2,3-dioxygenase by IFN-γ
MX Du et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2000)
Share Paper
